Regulus Therapeutics
RGLS
#7070
Rank
ยฃ0.42 B
Marketcap
ยฃ6.10
Share price
0.00%
Change (1 day)
437.40%
Change (1 year)

Market capitalization of Regulus Therapeutics (RGLS)

Last known market cap: ยฃ0.42 Billion

On August 27, 2025 Regulus Therapeutics had a market cap of ยฃ0.42 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regulus Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ0.41 B421.89%
2024ยฃ80.38 M295.61%
2023ยฃ20.31 M6.54%
2022ยฃ19.07 M-44.02%
2021ยฃ34.06 M-45.84%
2020ยฃ62.89 M340.89%
2019ยฃ14.26 M120.67%
2018ยฃ6.46 M-91.92%
2017ยฃ79.99 M-17.11%
2016ยฃ96.5 M-68.86%
2015ยฃ0.30 B-38.54%
2014ยฃ0.50 B169.35%
2013ยฃ0.18 B34.04%
2012ยฃ0.13 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Sanofi
SNY
ยฃ77.96 B 18,369.21%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
ยฃ21.02 B 4,879.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ88.96 B 20,976.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ213.95 B 50,585.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ76.54 B 18,032.78%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
ยฃ46.12 M-89.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
ยฃ2.22 B 427.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ29.35 B 6,855.08%๐Ÿ‡บ๐Ÿ‡ธ USA